LIC MF HEALTHCARE FUND holds 27 instruments (97.53% equity), led by Sun Pharmaceutical Industries Limited (9.59%), Divi's Laboratories Limited (9.07%) and Neuland Laboratories Limited (6.14%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of LIC MF HEALTHCARE FUND, managed by LIC Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 27 instruments with an equity allocation of 97.53%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
LIC MF HEALTHCARE FUND's top 10 holdings account for 60.15% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 92.55% of net assets, spread across 2 sectors in total. Since its 31 August 2026 disclosure, the fund added 2 new positions and exited 0 positions, with Artemis Medicare Services Limited seeing the largest move (-1.62pp to 1.26%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Max Healthcare Institute Limited | 2.55% → 2.99% | ▲ +0.44 |
| Syngene International Limited | 0.97% → 1.38% | ▲ +0.41 |
| Mankind Pharma Limited | 2.89% → 3.11% | ▲ +0.22 |
| Metropolis Healthcare Limited | 3.17% → 3.35% | ▲ +0.18 |
| Zydus Lifesciences Limited | 4.79% → 4.97% | ▲ +0.18 |
| Stock | Weight | Change |
|---|---|---|
| Artemis Medicare Services Limited | 2.88% → 1.26% | ▼ -1.62 |
| IPCA Laboratories Limited | 3.18% → 2.33% | ▼ -0.85 |
| Gland Pharma Limited | 3.93% → 3.2% | ▼ -0.73 |
| Navin Fluorine International Limited | 5.65% → 4.98% | ▼ -0.67 |
| Global Health Limited | 3.19% → 2.59% | ▼ -0.6 |
| Sun Pharmaceutical Industries Limited | 10.09% → 9.59% | ▼ -0.5 |
| Apollo Hospitals Enterprise Limited | 6.23% → 5.75% | ▼ -0.48 |
| Torrent Pharmaceuticals Limited | 6.45% → 6.04% | ▼ -0.41 |
| Glenmark Pharmaceuticals Limited | 2.88% → 2.61% | ▼ -0.27 |
| Neuland Laboratories Limited | 6.38% → 6.14% | ▼ -0.24 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: LIC Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.